SCHEMBL851325

SCHEMBL851325

FC(F)(F)C(F)(F)c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 7/20 0.53
▸ KIF11 P52732 1/20 0.44
▸ KCNA5 P22460 2/20 0.43
▸ CYP3A4 P08684 3/20 0.42
▸ CYP3A5 P20815 1/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29583661 1.00 CYP19A1 (0.53) CYP19A1KIF11KCNA5CYP3A4CYP3A5
SCHEMBL22303441 0.83 CYP19A1 (0.52) CYP19A1KIF11KCNA5CYP3A4CYP3A5
SCHEMBL7068828 0.81 CYP19A1 (0.57) CYP19A1KIF11KCNA5CYP3A4CYP3A5
SCHEMBL29387897 0.81 CYP19A1 (0.57) CYP19A1KIF11KCNA5CYP3A4CYP3A5
SCHEMBL13577 0.81 CYP19A1 (0.57) CYP19A1KIF11KCNA5CYP3A4CYP3A5
Bromide SCHEMBL29204966 0.79 CYP19A1 (0.55) CYP19A1KIF11KCNA5CYP3A4CYP3A5
Lithium SCHEMBL30216964 0.79 CYP19A1 (0.55) CYP19A1KIF11KCNA5CYP3A4CYP3A5
Hydrochloric Acid SCHEMBL21796041 0.79 CYP19A1 (0.55) CYP19A1KIF11KCNA5CYP3A4CYP3A5
Ammonia Solution, Strong SCHEMBL28655959 0.79 CYP19A1 (0.55) CYP19A1KIF11KCNA5CYP3A4CYP3A5
Benzene SCHEMBL29164330 0.79 CYP19A1 (0.55) CYP19A1KIF11KCNA5CYP3A4CYP3A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4318630-B1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY ASAHI CHEMICAL IND (JP) 2025-10-22 — — EP disclosed
US-12199280-B2 Non-aqueous secondary battery and non-aqueous electrolyte ASAHI KASEI KABUSHIKI KAISHA (JP) 2025-01-14 — — US disclosed
EP-4415105-A2 NON-AQUEOUS SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE Asahi Kasei Kabushiki Kaisha (JP) 2024-08-14 — — EP disclosed
US-20240178452-A1 Nonaqueous Electrolyte Solution and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-05-30 — — US disclosed
EP-4318630-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY Asahi Kasei Kabushiki Kaisha (JP) 2024-02-07 — — EP disclosed
WO-2022203072-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS SECONDARY BATTERY 旭化成株式会社 2022-09-29 — — WO disclosed
US-20220293929-A1 Non-Aqueous Secondary Battery and Non-Aqueous Electrolyte ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-09-15 — — US disclosed
EP-4009398-A1 NON-AQUEOUS SECONDARY BATTERY AND NON-AQUEOUS ELECTROLYTE Asahi Kasei Kabushiki Kaisha (JP) 2022-06-08 — — EP disclosed
US-10693189-B2 Nonaqueous electrolyte and nonaqueous secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-06-23 — — US disclosed
EP-3279996-B1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY ASAHI CHEMICAL IND (JP) 2018-12-26 — — EP disclosed
US-20180062207-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 — — US disclosed
EP-3279996-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS SECONDARY BATTERY Asahi Kasei Kabushiki Kaisha (JP) 2018-02-07 — — EP disclosed
EP-2432780-A1 PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL Sumitomo Chemical Company, Limited (JP) 2012-03-28 — — EP disclosed
WO-2010134478-A1 PYRIMIDINE COMPOUND AND ITS USE IN PEST CONTROL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220293929-A1 Non-Aqueous Secondary Battery and Non-Aqueous Electrolyte CLK2, TYK2, CLK3 CYP19A1 3486/4885KIF11 1596/4885KCNA5 763/4885
US-12199280-B2 Non-aqueous secondary battery and non-aqueous electrolyte CLK2, TYK2, CLK3 CYP19A1 3486/4885KIF11 1596/4885KCNA5 763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback